Patent review: therapeutic applications for antisense oligonucleotides 1999-2000

Over 200 patents disclosing antisense sequences have been published in the last year. 30 Of these, in which a therapeutic application is claimed, have been reviewed in this article. We have classified these under the headings of antibacterial, antiviral, inflammation, cardiovascular, apoptosis and a...

Full description

Saved in:
Bibliographic Details
Published inCurrent opinion in molecular therapeutics Vol. 2; no. 3; p. 325
Main Authors Orr, R M, O'Neill, C F
Format Journal Article
LanguageEnglish
Published England 01.06.2000
Subjects
Animals
Antineoplastic Agents - therapeutic use
Antiviral Agents - therapeutic use
Apoptosis - drug effects
Bacteria - drug effects
Bacteria - growth & development
Cardiovascular Diseases - drug therapy
Cell Division - drug effects
Humans
Inflammation - drug therapy
Oligonucleotides, Antisense - therapeutic use
Patents as Topic
Signal Transduction - drug effects
Online AccessGet more information

Cover

More Information
Summary:Over 200 patents disclosing antisense sequences have been published in the last year. 30 Of these, in which a therapeutic application is claimed, have been reviewed in this article. We have classified these under the headings of antibacterial, antiviral, inflammation, cardiovascular, apoptosis and anticancer. Although not exhaustive or covering all diseases, major areas of antisense research have been addressed.
ISSN:1464-8431